Head and Neck Cancer Trends in Semarang: An analysis of ASR and ASCR

Background: The sustainable incidence data of Head and Neck Cancer is poorly described in Indonesia. There was no large-scale epidemiological study of head and neck cancer in Indonesia, especially in Semarang and surrounding areas. Whereas, by knowing the distribution of sex and age in the incidence data could indicate changes in patterns of cancer that occur every year. Aim: This research aim to determine the distribution of head and neck cancer based on anatomic site, age and sex by counting the Age Standardization Rates (ASR) and Age Standardization Cancer Ratio (ASCAR) score Methods : This research was a retrospective observational descriptive study using the medical records of Head and Neck Cancer Patients from Anatomical Pathology Laboratory of Kariadi Central Hospital / Medical Faculty Diponegoro University and Waspada Laboratory in 2010- 2014. Collected data were tabulated manually using Microsoft Excel and analyzed and presented descriptively in table or graphic form Result: The incidences of head and neck cancer were varies every year. The nasopharyngeal cancer seems to be the most common head and neck cancer diagnosed during 2010- 2014. ASCR and ASR in male and female were different in certain head and neck cancer cases. Generally, ASR in male was higher than in females. Conclusion: The trends of head and neck cancer mostly in men. Based on age it distributed mostly in age group 40- 44.Nasopharyngeal cancer is the most cases diagnosed in this period in both male and female and followed with the neoplasm of nasal cavity and middle ear. Age Standardization used in this research allows this research’s result to be compared with the result in another population which used the same method. Keywords Head and Neck Cancer, ASR, ASC

Functional radical cervical dissection for differentiated thyroid cancer: the experience of a single center

There is ongoing debate regarding the role of neck dissection in differentiated thyroid cancer, about its usefulness in elective settings, and the increased costs regarding morbidity and operative time. This retrospective study aimed to determine the rate of metastases in cervical lymph nodes, to examine the morbidity of this surgery, and to assess whether a pattern of distribution of tumor cells concerning neck lymphatic compartments exists. The most frequent type of cancer to metastasize was papillary cancer, the majority of patients were young with a median of 30 years, predominantly females. Differentiated thyroid cancer frequently metastasizes to the central and lateral compartments of the neck. The morbidity is minimal in a high-volume center. Radical neck dissection is safe and feasible in selected patients with confirmed invaded or enlarged lymph nodes due to differentiated thyroid cancer, and postoperative complications are minimal if the anatomy is correctly identified and the cases strictly selected

De novo head and neck cancer after liver transplant with antibody-based immunosuppression induction

Background Powerful antibody-based immunosuppression induction is now used routinely during organ transplantation, and may place patients at even higher risk of post-transplant cancer. Materials and Methods Incidence of de-novo head and neck cancer was extracted from the records of 1685 consecutive adult, deceased donor liver transplant recipients with a minimum 1-year follow-up from 2001 to 2015. There were 121 patients positively identified as having developed de-novo head and neck cancer post-liver transplant. Records of these patients were analyzed to determine demographics, history of cancer pre-liver transplant, de-novo cancer type and location, treatment modalities, and alcohol and tobacco exposure. Results Of the 121 patients who developed cancer of the head and neck (7%), there were 103 cutaneous (6%) and 25 non-cutaneous (1%). For non-cutaneous cancers, factors associated with increased risk of cancer included alcohol abuse (p<0.001), any smoking history (p=0.05), and increasing exposure to tobacco (p<0.01). Ten-year Cox regression patient survival demonstrates a survival disadvantage for patients who develop non-cutaneous cancer (p=0.06), but a survival advantage for patients who develop cutaneous cancer (p<0.01). Conclusions The incidence and pattern of head and neck cancer in this population of liver transplant patients was similar to those published previously, suggesting that induction immunosuppression does not increase risk of these types of cancers. Long term survival was worse for patients with non-cutaneous cancers, but better for those with cutaneous cancers, though the reason is unclear

Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study

Background: There is evidence that cancer survivors are at increased risk of second primary cancers. Changes in the prevalence of risk factors and diagnostic techniques may have affected more recent risks.&lt;p&gt;&lt;/p&gt; Methods: We examined the incidence of second primary cancer among adults in the West of Scotland, UK, diagnosed with cancer between 2000 and 2004 (n = 57,393). We used National Cancer Institute Surveillance Epidemiology and End Results and International Agency for Research on Cancer definitions of multiple primary cancers and estimated indirectly standardised incidence ratios (SIR) with 95% confidence intervals (CI).&lt;p&gt;&lt;/p&gt; Results: There was a high incidence of cancer during the first 60 days following diagnosis (SIR = 2.36, 95% CI = 2.12 to 2.63). When this period was excluded the risk was not raised, but it was high for some patient groups; in particular women aged &#60;50 years with breast cancer (SIR = 2.13, 95% CI = 1.58 to 2.78), patients with bladder (SIR = 1.41, 95% CI = 1.19 to 1.67) and head &#38; neck (SIR = 1.93, 95% CI = 1.67 to 2.21) cancer. Head &#38; neck cancer patients had increased risks of lung cancer (SIR = 3.75, 95% CI = 3.01 to 4.62), oesophageal (SIR = 4.62, 95% CI = 2.73 to 7.29) and other head &#38; neck tumours (SIR = 6.10, 95% CI = 4.17 to 8.61). Patients with bladder cancer had raised risks of lung (SIR = 2.18, 95% CI = 1.62 to 2.88) and prostate (SIR = 2.41, 95% CI = 1.72 to 3.30) cancer.&lt;p&gt;&lt;/p&gt; Conclusions: Relative risks of second primary cancers may be smaller than previously reported. Premenopausal women with breast cancer and patients with malignant melanomas, bladder and head &#38; neck cancers may benefit from increased surveillance and advice to avoid known risk factors

EPIDEMIOLOGICAL STUDY ON HEAD AND NECK MALIGNANCIES - A STUDY OF 150 CASES

OBJECTIVE: In the present study we investigate the head and Neck Malignancy cases presenting to the ENT department of our Hospital, and analyze the same to give inputs as to the incidence of head and neck malignancies, the symptoms and stage of presentation, lifestyle and habits as contributory risk factors, identify ENT primary in neck secondaries, histopathological types and selection of best treatment.METHODS: Prospective analysis of 150 patients with newly diagnosed malignancies of nasopharynx, oropharynx, larynx, hypopharynx and ear.RESULTS: Most malignancies are common in patients greater than 40 years of age. 88% of cancer occur in males. Oropharynx cancer is the most common cancer in our study, with the commonest subsite as base of tongue. Supraglottic and pyriform fossa tumours are the commonest tumour in laryngeal and hypopharyngeal cancers  respectively. The most common presentation is dysphagia. Synergistic effect of smoking and alcohol is seen in 50% of patients. Most of the cases were seen in stage III and IV except glottis cancer which is predominantly seen in stage I, almost all cases were squamous cell carcinoma.CONCLUSION:The results of our study were in conformity with other similar studies. In larynx, Supraglottic was more common as opposed to glottis in certain western studies. Analysis of various factors helps in early diagnosis and management.KEYWORDS:Cancer, Head and Neck Malignancy, Larynx, pharynx, Nasopharynx, Neck secondaries.

Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo

Violacein (VIO; 3-[1,2-dihydro-5-(5-hydroxy-1H-indol-3-yl)-2-oxo-3H-pyrrol-3-ylidene]-1,3-dihydro-2H-indol-2-one), an indole-derived purple-colored pigment, produced by a limited number of Gram-negative bacteria species, including Chromobacterium violaceum and Janthinobacterium lividum, has been demonstrated to have anti-cancer activity, as it interferes with survival transduction signaling pathways in different cancer models. Head and neck carcinoma (HNC) represents the sixth most common and one of the most fatal cancers worldwide. We determined whether VIO was able to inhibit head and neck cancer cell growth both in vitro and in vivo. We provide evidence that VIO treatment of human and mouse head and neck cancer cell lines inhibits cell growth and induces autophagy and apoptosis. In fact, VIO treatment increased PARP-1 cleavage, the Bax/Bcl-2 ratio, the inhibition of ERK1 and ERK2 phosphorylation, and the expression of light chain 3-II (LC3-II). Moreover, VIO was able to induce p53 degradation, cytoplasmic nuclear factor kappa B (NF-κB) accumulation, and reactive oxygen species (ROS) production. VIO induced a significant increase in ROS production. VIO administration was safe in BALB/c mice and reduced the growth of transplanted salivary gland cancer cells (SALTO) in vivo and prolonged median survival. Taken together, our results indicate that the treatment of head and neck cancer cells with VIO can be useful in inhibiting in vivo and in vitro cancer cell growth. VIO may represent a suitable tool for the local treatment of HNC in combination with standard therapies

The impact of Coronavirus (COVID-19) on head and neck cancer patients' care

The impact of Coronavirus (COVID-19) on head and neck cancer patients' care

Life as an early career researcher: Ruth Bower

Ruth Bower talks to Francesca Lake, Managing Editor: Ruth is currently researching head and neck cancer chemoradiotherapy regimens utilizing microfluidic technology to maintain and interrogate biopsies. Tissue response is investigated using a variety of whole tissue and cellular analytical techniques with a view toward personalized medicine. She is currently pursuing her PhD within the head and neck cancer research group at Hull University (UK). Ruth obtained a first class (Hons) degree in Biological Sciences from Lancaster University (UK) during which time she spent a year at the University of Wollongong (Australia)

PERBEDAAN SKOR GERIATRIC DEPRESSION SCALE PADA PASIEN USIA LANJUT DENGAN KANKER KEPALA DAN LEHER YANG BELUM DAN SEDANG MENJALANI RADIOTERAPI

Background. There has been a constant rise in the elderly population number throughout the world, more so in the developing countries. This growth is paralleled with rapid increase in disease prevalence, head and neck cancer being one of them. The diagnosis and subsequent treatment such as radiotherapy can have a potentially devastating impact on psychosocial functioning, including depression. Aims. This study aims to compare the total Geriatric Depression Scale (GDS) mean score between two groups of sample: those who had not yet undergone radiotherapy and those who had a minimum of 10 times radiotherapy. Methods. Cross-sectional analysis was conducted on 28 elderly head and neck cancer patients from the Radiotherapy Department, Kariadi Hospital, Semarang from April to August 2015. Sosiodemographic characteristics and clinical data including diagnosis, cancer stage, and radiotherapy frequency were obtained from the medical records, followed by a questionnaire-based interview afterwards. Statistical analysis using Independent T-test was performed. Results. The mean of total GDS score was significantly higher among patients within the course of the therapy compared to the other group with scores of 2,64(±1,82) and 6,64(±3,41) respectively (p=0,001). Cancer stage contributed an extremely weak positive correlation to the GDS score (r=0,141) Conclusion. Patients within the course of radiotherapy were more depressed compared to the comparative group. Key word: geriatric population, head and neck cancer, depression, geriatric depression scale (GDS), radiotherap

Psychosocial interventions for patients with head and neck cancer.

BACKGROUND: A diagnosis of head and neck cancer, like many other cancers, can lead to significant psychosocial distress. Patients with head and neck cancer can have very specific needs, due to both the location of their disease and the impact of treatment, which can interfere with basic day-to-day activities such as eating, speaking and breathing. There is a lack of clarity on the effectiveness of the interventions developed to address the psychosocial distress experienced by patients living with head and neck cancer. OBJECTIVES: To assess the effectiveness of psychosocial interventions to improve quality of life and psychosocial well-being for patients with head and neck cancer. SEARCH METHODS: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled Trials (CENTRAL); PubMed; EMBASE; CINAHL; Web of Science; BIOSIS Previews; Cambridge Scientific Abstracts; ICTRP and additional sources for published and unpublished trials. The date of the most recent search was 17 December 2012. SELECTION CRITERIA: We selected randomised controlled trials and quasi-randomised controlled trials of psychosocial interventions for adults with head and neck cancer. For trials to be included the psychosocial intervention had to involve a supportive relationship between a trained helper and individuals diagnosed with head and neck cancer. Outcomes had to be assessed using a validated quality of life or psychological distress measure, or both. DATA COLLECTION AND ANALYSIS: Two review authors independently selected trials, extracted data and assessed the risk of bias, with mediation from a third author where required. Where possible, we extracted outcome measures for combining in meta-analyses. We compared continuous outcomes using either mean differences (MD) or standardised mean differences (SMD) and 95% confidence intervals (CI), with a random-effects model. We conducted meta-analyses for the primary outcome measure of quality of life and secondary outcome measures of psychological distress, including anxiety and depression. We subjected the remaining outcome measures (self esteem, coping, adjustment to cancer, body image) to a narrative synthesis, due to the limited number of studies evaluating these specific outcomes and the wide divergence of assessment tools used. MAIN RESULTS: Seven trials, totaling 542 participants, met the eligibility criteria. Studies varied widely on risk of bias, interventions used and outcome measures reported. From these studies, there was no evidence to suggest that psychosocial intervention promotes global quality of life for patients with head and neck cancer at end of intervention (MD 1.23, 95% CI -5.82 to 8.27) as measured by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). This quality of life tool includes five functional scales, namely cognitive, physical, emotional, social and role. There was no evidence to demonstrate that psychosocial intervention provides an immediate or medium-term improvement on any of these five functional scales. From the data available, there was no significant change in levels of anxiety (SMD -0.09, 95% CI -0.40 to 0.23) or depression following intervention (SMD -0.03, 95% CI -0.24 to 0.19). At present, there is insufficient evidence to refute or support the effectiveness of psychosocial intervention for patients with head and neck cancer. AUTHORS' CONCLUSIONS: The evidence for psychosocial intervention is limited by the small number of studies, methodological shortcomings such as lack of power, difficulties with comparability between types of interventions and a wide divergence in outcome measures used. Future research should be targeted at patients who screen positive for distress and use validated outcome measures, such as the EORTC scale, as a measure of quality of life. These studies should implement interventions that are theoretically derived. Other shortcomings should be addressed in future studies, including using power calculations that may encourage multi-centred collaboration to ensure adequate sample sizes are recruited